Development accomplishments of the Korean pharmaceutical industry's blood cancer treatments will be showcased at an international conference. Hanmi Pharmaceutical, PharosiBio, LigaChem Biosciences, and Aptamer Sciences will present their promising clinical study results, and they are set to join the global stage.

PharosiBio and Hanmi Pharmaceutical will present their clinical accomplishment of new drug candidates for acute myeloid leukemia (AML). Aptamer Sciences and LigaChem Biosciences will unveil the competitiveness of their antibody-drug candidate (ADC) platforms.

Clinical results of AML will be showcased…new drug discovery platform competitiveness ↑